Try our Advanced Search for more refined results

October 16, 2017

Endo Pharmaceuticals Inc. v. Actavis LLC

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 03, 2019

    Fed. Circ. Upholds Opana Patent Amid Generic Challenge

    The Federal Circuit on Friday upheld the validity of a patent related to Endo Pharmaceuticals' opioid painkiller Opana ER, finding generic-drug maker Teva Pharmaceuticals had not shown the invention was obvious.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login